Treatment aiming at reducing Hb/metHb formation and inflammation in the intraventricular space, thus reducing damage to the ependymal cells lining the choroid plexus and the ventricles, might decrease the ensuing brain damage as well as the risk of developing hydrocephalus. This evidence concerns the gene GSTM1 and Hydrocephalus.